Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Design Therapeutics Inc

DSGN
Current price
2.51 USD +0.11 USD (+4.58%)
Last closed 2.4 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 124 324 440 USD
Yield for 12 month -81.64 %
Week
Month
Year
DSGN
21.11.2021 - 28.11.2021

Design Therapeutics, Inc. a preclinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions. The company's portfolio of products comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ systems dependent on mitochondrial function, eventually leading to neurological, cardiac, and metabolic dysfunction; and Myotonic Dystrophy Type-1 (DM1), a dominantly-inherited, monogenic progressive neuromuscular disease affecting skeletal muscle, heart, brain, and other organs. It is also developing GeneTAC product candidate portfolio for the treatment of other nucleotide repeat expansion-driven monogenic diseases, such as Fragile X syndrome, spinocerebellar ataxias, amyotrophic lateral sclerosis, frontotemporal dementia, Huntington disease, and spinobulbar muscular atrophy. The company was incorporated in 2017 and is headquartered in Carlsbad, California. Address: 6005 Hidden Valley Road, Carlsbad, CA, United States, 92011

Analytics

WallStreet Target Price

4.75 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

Current Quarter

Last Quarter

Key Figures DSGN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -81 938 000 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -15.75 %
PEG Ratio
Return On Equity TTM -23.12 %
Wall Street Target Price 4.75 USD
Revenue TTM 33 000 USD
Book Value 5.09 USD
Revenue Per Share TTM 0.001 USD
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM -48 613 000 USD
Earnings Share -1.29 USD
Diluted Eps TTM -1.29 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics DSGN

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History DSGN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation DSGN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 11004.3527
Price Sales TTM 22642.0122
Enterprise Value EBITDA -1.68
Price Book MRQ 1.289

Financials DSGN

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators DSGN

For 52 weeks

1.94 USD 15.52 USD
50 Day MA 2.23 USD
Shares Short Prior Month 2 943 176
200 Day MA 4.99 USD
Short Ratio 10.35
Shares Short 3 117 783
Short Percent 9.26 %